Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Red wine mist? Resveratrol shows potential effects against COPD, asthma, arthritis

28.10.2004


Natural product inhibited anti-inflammatory mediator release from human airway epithelial cells

Homing in on mechanisms for the reported effectiveness of resveratrol, which is found in red wine, researchers at Imperial College London, England, confirmed its broad anti-inflammatory action, and found potential for applications in chronic obstructive pulmonary disease (COPD), asthma, and possibly even arthritis. Clinical preparation and delivery remain issues, though an aerosol version would have obvious benefits.

Indeed, lead researcher Louise Donnelly said "Resveratrol exhibited anti-inflammatory activity in all the systems we examined: laboratory cells lines as well as ’real’ human airway epithelial cells," or HAEC. The research paper published by Donnelly et al. in the American Journal of Physiology-Lung Cellular and Molecular Physiology, notes: "Our study is novel as it examines the anti-inflammatory mechanism(s) of resveratrol in cells relevant to human disease and explores all of the proposed mechanisms in a single study."



Most importantly, resveratrol "inhibited anti-inflammatory mediator release from human airway epithelial cells." And contrary to earlier conjecture, the Imperial College researchers showed that "resveratrol did not act as an estrogen or glucocorticosteroid," each of which have patient acceptance issues.

Resveratrol from red wine has long been associated with the so-called "French Paradox," reflecting the low incidence of heart disease among the French despite their relatively high-fat diet. It is a polyphenolic compound found in the skins of such red fruits as grapes and plums, the red skin of peanuts, and even peanut butter. However, Donnelly noted there’s "no evidence that COPD, asthma (especially in asthmatic smokers) or related diseases have lower incidence in France or elsewhere in the Mediterranean region."

OTC versions not useful: aerosol version needed

Moreover, Donnelly warned that their research group had "looked at the over-the-counter" versions of resveratrol and found that "it’s not very pure and probably wouldn’t be worth taking." The major problem is bioavailability. The compound dissolves only in certain solvents, including alcohol, "and is cleared very rapidly in the liver," Donnelly said.

Especially for such respiratory diseases as COPD and asthma, developing an aerosol version for inhalation probably would be a better option," Donnelly said, noting that it would overcome one of the problems with steroids, which is noncompliance.

The current research aimed to confirm and quantify the effect of resveratrol and quercetin, a related plant-derived polyphenolic compound that often mimics its diverse activities, and to further study the molecular mechanisms involved.

While resveratrol "exhibited anti-inflammatory activity in all the systems we examined," the researchers said, "it appeared to be more effective, although less potent, than glucocorticoids. Resveratrol also inhibited inflammatory mediator release from human airway epithelial cells (HAEC), inhibited iNOS and COX-2 (cyclooxygenase) gene transcription, together with IL-8 and GM-CSF expression in HAEC. The inhibition of iNOS (inducible nitric oxide synthase) expression and activity in primary HAEC is significant, because steroids are ineffective in this system," the paper states.

IL-8 (interleukin-8) and GM-CSF (granulocyte-macrophage colony-stimulating factor) are important in the inflammation development, they noted, because IL-8 plays a major role in the recruitment of inflammatory leukocytes, particularly neutrophils, and GM-CSF is a cell survivor factor, thus prolonging the resident time of inflammatory cells. "The differential inhibitory effects of resveratrol on IL-8 and GM-CSF release (shown in this study) further suggest that resveratrol is not simply acting as a general inhibitor of inflammatory mediator release but exhibits some selectivity."

Next steps: further narrow mechanisms of broad anti-inflammatory

Donnelly et al. conclude that resveratrol and quercetin "can act as novel anti-inflammatory agents. Their mechanism of action is not via the estrogen or glucocorticoid receptor; thus these agents might be beneficial in inflammatory diseases where glucocorticosteroids have proved to be ineffective, such as COPD, steroid-resistant asthma, and arthritis. These compounds may provide candidate molecules for the development of novel anti-inflammatory therapies."

The current study "excluded a lot" of potential mechanisms of action, Donnelly said, but we "still don’t know what its target receptor is as it binds like a protein, but acts like an estrogen," which it’s not. "The good thing is that it does stop inflammation" across a broad range of systems, she added.

Source and funding: The article, "Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms," appears in the October issue of American Journal of Physiology-Lung Cellular and Molecular Physiology, published by the American Physiological Society.

In addition to Donnelly, other members of the research team, all from the Department of Thoracic Medicine, National Heart & Lung Institute, Imperial College London, England, are: Robert Newton, Gina E. Kennedy, Peter S. Fenwick, Rachel H.F. Leung, Kazuhiro Ito, Richard E.K. Russell and Peter J. Barnes.

Research was funded by grants from Pharmascience Inc., Pharmacia (part of Pfizer Inc.), the British Lung Foundation and the National Asthma Campaign (UK).

Mayer Resnick | EurekAlert!
Further information:
http://www.the-aps.org

More articles from Health and Medicine:

nachricht Electrical 'switch' in brain's capillary network monitors activity and controls blood flow
27.03.2017 | Larner College of Medicine at the University of Vermont

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Northern oceans pumped CO2 into the atmosphere

27.03.2017 | Earth Sciences

Fingerprint' technique spots frog populations at risk from pollution

27.03.2017 | Life Sciences

Big data approach to predict protein structure

27.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>